Show simple item record

dc.contributor.authorSebastian, M
dc.contributor.authorBarlesi, F
dc.contributor.authorCalifano, Raffaele
dc.contributor.authorMansfield, AS
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorFlahavan, EM
dc.contributor.authorDavies, J
dc.contributor.authorArnold, P
dc.contributor.authorMorris, S
dc.contributor.authorReck, M
dc.date.accessioned2020-03-27T09:28:00Z
dc.date.available2020-03-27T09:28:00Z
dc.date.issued2019en
dc.identifier.citationSebastian M, Barlesi F, Califano R, Mansfield AS, Blackhall FH, Flahavan EM, et al. Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice. Ann Oncol. 2019;30 Suppl 2:ii24.en
dc.identifier.pmid32131195en
dc.identifier.doi10.1093/annonc/mdz071.006en
dc.identifier.urihttp://hdl.handle.net/10541/622827
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz071.006en
dc.titleTreatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practiceen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversitatsklinikum Frankfurt (Johannes-Wolfgang Goethe Institute), Frankfurt am Main, Germanyen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]
refterms.dateFOA2020-03-31T08:30:21Z


Files in this item

Thumbnail
Name:
32131195.pdf
Size:
93.26Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record